Ignite Creation Date:
2024-05-06 @ 4:01 AM
Last Modification Date:
2024-10-26 @ 11:42 AM
Study NCT ID:
NCT02435433
Status:
COMPLETED
Last Update Posted:
2023-01-20
First Post:
2015-05-01
Brief Title:
A Study of Ramucirumab LY3009806 Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-01
First Submit QC Date:
May 1 2015
Study First Post Date:
2015-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-05-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-22
Last Update Post Date:
2023-01-20
Last Update Post Date Type:
ACTUAL